Publications

Focal Therapy

Valerio, M, Stricker PD, H. U. Ahmed, L. Dickinson, L. Ponsky, Shnier R, C. Allen, and M. Emberton. 2014. Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer. Prostate Cancer Prostatic Dis, 17: 343 https://doi.org/10.1038/pcan.2014.33
Ting F, M. Tran, M. Böhm, Siriwardana A, van Leeuwen PJ, Haynes AM, Delprado W, Shnier R, and Stricker PD. 2015. Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control. Prostate Cancer And Prostatic Diseases, 19: 46. https://doi.org/10.1038/pcan.2015.47
Ting F, van Leeuwen PJ, and Stricker PD. 2016. Step-by-Step Technique for Irreversible Electroporation of Focal Prostate Cancer: An Instructional Video Guide. J Vasc Interv Radiol, 27: 568. https://doi.org/10.1016/j.jvir.2016.01.003
Scheltema M.J, van den Bos W, Siriwardana AR, Kalsbeek AMF, Thompson JE, Ting F, Bohm M, Haynes AM, Shnier R, Delprado W, and Stricker PD. 2017. Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer. BJU Int, 120 Suppl 3: 51-58. https://doi.org/10.1111/bju.13991
Scheltema MJ, Chang JI, Bohm M, van den Bos W, A. Blazevski, Gielchinsky I, Kalsbeek AMF, van Leeuwen PJ, Nguyen TV T. M. de Reijke, Siriwardana AR, Thompson JE, J. J. de la Rosette, and Stricker PD. 2018. Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy. World J Urol. https://doi.org/10.1007/s00345-018-2281-z
Van den Bos W, Scheltema MJ, Siriwardana AR, Kalsbeek AMF, Thompson JE, Ting F, Bohm M, Haynes AM, Shnier R, Delprado W, and Stricker PD. 2018. Focal irreversible electroporation as primary treatment for localized prostate cancer. BJU Int, 121: 716-24. https://doi.org/10.1111/bju.13983
Scheltema MJ, Chang JI, van den Bos W, Gielchinsky I, Nguyen TV T. M. Reijke, Siriwardana AR, Bohm M, J. J. de la Rosette, and Stricker PD. 2018. Impact on genitourinary function and quality of life following focal irreversible electroporation of different prostate segments. Diagn Interv Radiol, 24: 268-75. https://doi.org/10.5152/dir.2018.17374
Scheltema M.J, T. J. O'Brien, van den Bos W, D. M. de Bruin, R. V. Davalos, C. W. M. van den Geld, M. P. Laguna, R. E. Neal, 2nd, I. M. Varkarakis, A. Skolarikos, Stricker PD, T. M. de Reijke, C. B. Arena and J. de la Rosette (2019). umerical simulation modeling of the irreversible electroporation treatment zone for focal therapy of prostate cancer, correlation with whole-mount pathology and T2-weighted MRI sequences. Ther Adv Urol 11: 1756287219852305. https://doi.org/10.1177/1756287219852305
Blazevski, A, Scheltema MJ, A. Amin, Thompson JE, N. Lawrentschuk and Stricker PD (2019). rreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment. BJU Int. https://doi.org/10.1111/bju.14951
Blazevski A, Scheltema MJ, Yuen B Masand N, Nguyen TV W.Delprado, Shnier R, A. Haynes, Cusick T, Thompson J, Stricker P. Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort. Eur Urol. Oncol(2019). https://doi.org/10.1016/j.euo.2019.04.008
Blazevski, A, Scheltema MJ, A. Amin, Thompson JE, N. Lawrentschuk and Stricker PD (2020). Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment. BJU Int 125(3): 369-378. https://doi.org/10.1111/bju.14951
Blazevski A, Amin A, Scheltema MJ, Balakrishnan A, Haynes AM, Barreto D, Cusick T, Thompson J, Stricker PD. Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE). World J Urol. 2021 Apr;39(4):1107-1114. https://doi.org/10.1007/s00345-020-03275-z  Epub 2020 Jun 2.
Blazevski A, Gondoputro W, Scheltema MJ, Amin A, Geboers B, Barreto D, Haynes AM, Shnier R, Delprado W, Agrawal S, Thompson JE, Stricker PD. Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes. BMC Urol. 2022 Mar 2;22(1):28. https://doi.org/10.1186/s12894-022-00978-w.
Geboers B, Gondoputro W, Thompson JE, Reesink DJ, van Riel LAMJG, Zhang D, Blazevski A, Doan P, Agrawal S, Matthews J, Haynes AM, Liu Z, Delprado W, Shnier R, de Reijke TM, Lawrentschuk N, Stijns PEF, Yaxley JW, Scheltema MJ, Stricker PD. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation-A Multicenter Validation Study. Eur Urol Focus. 2022 May 13:S2405-4569(22)00106-7. https://doi.org/10.1016/j.euf.2022.04.010. Epub ahead of print.
van Riel LAMJG, Geboers B, Kabaktepe E, Blazevski A, Reesink DJ, Stijns P, Stricker PD, Casanova J, Dominguez-Escrig JL, de Reijke TM, Scheltema MJ, Oddens JR. Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer. BJU Int. 2022 Apr 27. https://doi.org/10.1111/bju.15759. Epub ahead of print.
Ong S, Chen K, Grummet J, Yaxley J, Scheltema MJ, Stricker P, Tay KJ, Lawrentschuk N. Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus? BJU Int. 2022 Sep 9. https://doi.org/10.1111/bju.15883. Epub ahead of print.
Scheltema M.J, Geboers, B, Blazevski, A, Doan, P, Katelaris, A, Agrawal, S, Barreto, D, Shnier, R, Delprado, W, Thompson, J. E, & Stricker, P. D. (2022). Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer. BJU international, 10.1111/bju.15946. Advance online publication. https://doi.org/10.1111/bju.15946
Blazevski, A, Geboers, B, Scheltema M.J, Gondoputro, W, Doan, P, Katelaris, A, Agrawal, S, Baretto, D, Matthews, J, Haynes, A. M, Delprado, W, Shnier, R, Van den Bos W, Thompson, J. E, Lawrentschuk, N, & Stricker, P. D. (2022). Salvage irreversible electroporation for radio-recurrent prostate cancer - the prospective FIRE trial. BJU international, 10.1111/bju.15947. Advance online publication. https://doi.org/10.1111/bju.15947
Geboers, B, Scheltema M.J, Blazevski, A, Katelaris, A, Doan, P, Ali, I, Agrawal, S, Barreto, D, Matthews, J, Haynes, A. M, Delprado, W, Shnier, R, Thompson, J. E, & Stricker, P. D. (2023). Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer. BJU international, 10.1111/bju.15948. Advance online publication. https://doi.org/10.1111/bju.15948
Emberton M, Reijke T;, Stricker P, Miñana, Bianco F, Dominguez Escrig J, Lantz A, Sanchez-Salas R. Revisiting Delphi to create a basis for the future of focal therapy for prostate cancer. Urology Journal URL-D-23-00730
Lantz A, Nordlund P, Falagario U, Jäderling F, Özbek O, Clements M, Discacciati A, Grönberg H, Eklund M, Stricker P, Emberton M, Aly M, Nordström T. Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer. Eur Urol Open Sci. 2023 Apr 8;51:89-94. https://doi.org/10.1016/j.euros.2023.03.003 . PMID: 37091033; PMCID: PMC10114162.
Deivasigamani S, Kotamarti S, Rastinehad AR, et al. Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement. Eur Urol. 2023;84(6):547-560. https://doi.org/10.1016/j.eururo.2023.06.013. Epub ahead of print. PMID: 37419773.
Scheltema MJ, Katelaris A, Stricker PD. Salvage irreversible electroporation for radio-recurrent prostate cancer. Nat Rev Urol. 2023 Mar 1. https://doi.org/10.1038/s41585-023-00750-1 . Epub ahead of print. PMID: 36859611.
Rodríguez-Sánchez L, Emberton M, de Reijke T, Stricker P, Miñana B, Bianco F, Escrig JLD, Lantz A, Sanchez-Salas R. Revisiting Delphi to Create a Basis for the Future of Focal Therapy for Prostate Cancer. World J Mens Health. 2023 Oct 16. DOI: 10.5534/wjmh.230160. Epub ahead of print. PMID: 37853538.
Zhang K, Stricker P, Löhr M, Stehling M, Suberville M, Cussenot O, Lunelli L, Ng CF, Teoh J, Laguna P, de la Rosette J. A multi-center international study to evaluate the safety, functional and oncological outcomes of irreversible electroporation for the ablation of prostate cancer.  Prostate cancer and prostatic diseases. 2024 Jan 9. https://doi.org/10.1038/s41391-023-00783-y. Epub ahead of print. PMID: 38195916.
Geboers B, Meijer D, Counter W, et al. Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy. BJU Int. 2024;133 Suppl 4:14-22. https://doi:10.1111/bju.16207
Williams ISC, Katelaris A, Geboers B, Doan P, Delprado W, Scheltema MJ, Stricker P. Transrectal Ultrasound as Real-Time Confirmation of Adequate Needle Positioning During Irreversible Electroporation in Focal Therapy of Prostate Cancer. Videourology 37, pp. 1 - 2 https://doi.org/10.1089/vid.2023.0046
Geboers B, Scheltema MJ, Jung J, Stricker PD. Irreversible Electroporation of Intermediate risk prostate cancer mitigates immune suppression and induces systemic antitumor T cell activation Presented at USANZ Annual Scientific Meeting 2024

Active Surveillance

Amin, A., Scheltema, M. J., Shnier, R., Blazevski, A., Moses, D., Cusick, T., … Thompson, J. (2020). The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies. The Journal of Urology , 203 (5), 910–917. https://doi.org/10.1097/JU.0000000000000693
Bayliss, D. R., Duff, J., Stricker, P., & Walker, K. (2017). Decision-Making in Prostate Cancer – Choosing Active Surveillance Over Other  Treatment Options: A Literature Review. Urologic Nursing , 37 (1), 15–22.
Grogan, J., Gupta, R., Mahon, K. L., Stricker, P. D., Haynes, A.-M., Delprado, W., … Kench, J. G. (2017). Predictive value of the 2014 International Society of Urological Pathology grading  system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up. BJU International , 120 (5), 651–658. https://doi.org/10.1111/bju.13857
Hossack, T., Patel, M. I., Huo, A., Brenner, P., Yuen, C., Spernat, D., … Stricker, P. (2012). Location and pathological characteristics of cancers in radical prostatectomy  specimens identified by transperineal biopsy compared to transrectal biopsy. The Journal of Urology , 188 (3), 781–785. https://doi.org/10.1016/j.juro.2012.05.006
Huo, A. S. Y., Hossack, T., Symons, J. L. P., PeBenito, R., Delprado, W. J., Brenner, P., & Stricker, P. D. (2012). Accuracy of primary systematic template guided transperineal biopsy of the prostate  for locating prostate cancer: a comparison with radical prostatectomy specimens. The Journal of Urology , 187 (6), 2044–2049. https://doi.org/10.1016/j.juro.2012.01.066
King, M. T., Viney, R., Smith, D. P., Hossain, I., Street, D., Savage, E., … Armstrong, B. K. (2012). Survival gains needed to offset persistent adverse treatment effects in localised  prostate cancer. British Journal of Cancer , 106 (4), 638–645. https://doi.org/10.1038/bjc.2011.552
Olivier, J., Li, W., Nieboer, D., Helleman, J., Roobol, M., Gnanapragasam, V., … Villers, A. (2022). Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic  Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consort. European Urology Open Science , 35 , 59–67. https://doi.org/10.1016/j.euros.2021.11.006
Quinn, D. I., Henshall, S. M., Brenner, P. C., Kooner, R., Golovsky, D., O’Neill, G. F., … Stricker, P. D. (2003). Prognostic significance of preoperative factors in localized prostate carcinoma  treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion. Cancer , 97 (8), 1884–1893. https://doi.org/10.1002/cncr.11263
Rasiah, K. K., Stricker, P. D., Haynes, A.-M., Delprado, W., Turner, J. J., Golovsky, D., … Henshall, S. M. (2003). Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate  carcinoma. Cancer , 98 (12), 2560–2565. https://doi.org/10.1002/cncr.11850
Symons, J. L., Huo, A., Yuen, C. L., Haynes, A.-M., Matthews, J., Sutherland, R. L., … Stricker, P. D. (2013). Outcomes of transperineal template-guided prostate biopsy in 409 patients. BJU International , 112 (5), 585–593. https://doi.org/10.1111/j.1464-410X.2012.11657.x
Thompson, J. E., Hayen, A., Landau, A., Haynes, A.-M., Kalapara, A., Ischia, J., … Stricker, P. D. (2015). Medium-term oncological outcomes for extended vs saturation biopsy and transrectal  vs transperineal biopsy in active surveillance for prostate cancer. BJU International , 115 (6), 884–891. https://doi.org/10.1111/bju.12858
Ting, F., van Leeuwen, P. J., Delprado, W., Haynes, A.-M., Brenner, P., & Stricker, P. D. (2015). Tumor volume in insignificant prostate cancer: Increasing the threshold is a safe  approach to reduce over-treatment. The Prostate , 75 (15), 1768–1773. https://doi.org/10.1002/pros.23062
van Leeuwen, P. J., Siriwardana, A., Roobol, M., Ting, F., Nieboer, D., Thompson, J., … Stricker, P. (2016). Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies. Prostate Cancer , 2016 , 7105678. https://doi.org/10.1155/2016/7105678

Imaging

Algohary, A., Shiradkar, R., Pahwa, S., Purysko, A., Verma, S., Moses, D., … Madabhushi, A. (2020). Combination of Peri-Tumoral and Intra-Tumoral Radiomic Features on Bi-Parametric MRI  Accurately Stratifies Prostate Cancer Risk: A Multi-Site Study. Cancers , 12 (8). https://doi.org/10.3390/cancers12082200
Algohary, A., Viswanath, S., Shiradkar, R., Ghose, S., Pahwa, S., Moses, D., … Madabhushi, A. (2018). Radiomic features on MRI enable risk categorization of prostate cancer patients on  active surveillance: Preliminary findings. Journal of Magnetic Resonance Imaging : JMRI . https://doi.org/10.1002/jmri.25983
Emmett, L., Buteau, J., Papa, N., Moon, D., Thompson, J., Roberts, M. J., … Stricker, P. (2021). The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron  Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study. European Urology , 80 (6), 682–689. https://doi.org/10.1016/j.eururo.2021.08.002
Emmett, L., Tang, R., Nandurkar, R., Hruby, G., Roach, P., Watts, J. A., … Science, M. (2019). 3 year freedom from progression following 68 GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy . Results of a prospective multi‐center. Journal of Nuclear Medicine , epub ahead . https://doi.org/10.2967/jnumed.119.235028
Emmett, L., Van Leeuwen, P., Nandurkar, R., Scheltema, M. J., Cusick, T., Hruby, G., … Stricker, P. (2017). Treatment outcomes from 68 GaPSMA PET CT informed salvage radiation treatment in men with rising PSA following radical prostatectomy: Prognostic value of a negative PSMA PET. Journal of Nuclear Medicine , jnumed.117.196683. https://doi.org/10.2967/jnumed.117.196683
Huits, T. H., Luiting, H. B., van der Poel, H. G., Nandurkar, R., Donswijk, M., Schaake, E., … van Leeuwen, P. J. (2020). Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane  antigen ((68) Ga-PSMA) positron-emission/computed tomography after radical prostatectomy with pathological node-positive extended lymph node dissection. BJU International , 125 (6), 876–883. https://doi.org/10.1111/bju.15052
Morigi, J. J., Stricker, P. D., van Leeuwen, P. J., Tang, R., Ho, B., Nguyen, Q., … Emmett, L. (2015). Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in  Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine , 56 (8), 1185–1190. https://doi.org/10.2967/jnumed.115.160382
Nandurkar, R., van Leeuwen, P., Stricker, P., Woo, H., Kooner, R., Yuen, C., … Emmett, L. (2019). (68)Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate  cancer patients: Diagnostic and predictive value for the biochemical response to surgery. The British Journal of Radiology , 92 (1095), 20180667. https://doi.org/10.1259/bjr.20180667
Penzias, G., Singanamalli, A., Elliott, R., Gollamudi, J., Shih, N., Feldman, M., … Madabhushi, A. (2018). Identifying the morphologic basis for radiomic features in distinguishing different  Gleason grades of prostate cancer on MRI: Preliminary findings. PloS One , 13 (8), e0200730. https://doi.org/10.1371/journal.pone.0200730
Roach, P. J., Francis, R., Emmett, L., Hsiao, E., Kneebone, A., Hruby, G., … Scott, A. M. (2018). The Impact of (68)Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of  an Australian Prospective Multicenter Study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine , 59 (1), 82–88. https://doi.org/10.2967/jnumed.117.197160
Rusu, M., Purysko, A. S., Verma, S., Kiechle, J., Gollamudi, J., Ghose, S., … Madabhushi, A. (2017). Computational imaging reveals shape differences between normal and malignant  prostates on MRI. Scientific Reports , 7 , 41261. https://doi.org/10.1038/srep41261
Thompson, J. E., Van Leeuwen, P. J., Moses, D., Shnier, R., Brenner, P., Delprado, W., … Stricker, P. D. (2016). The diagnostic performance of multiparametric magnetic resonance imaging to detect significant prostate cancer. Journal of Urology , 195 (5), 1428–1435. https://doi.org/10.1016/j.juro.2015.10.140
Thompson, James E., Moses, D., Shnier, R., Brenner, P., Delprado, W., Ponsky, L., … Stricker, P. D. (2014). Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: A prospective study. Journal of Urology , 192 (1), 67–74. https://doi.org/10.1016/j.juro.2014.01.014
Thompson, James E, & Stricker, P. D. (2017). Diagnostic accuracy of multi-parametric MRI and transrectal ultrasound-guided biopsy  in prostate cancer. Lancet (London, England) , 389 (10071), 767–768. https://doi.org/10.1016/S0140-6736(17)30121-6
Tran, M., Thompson, J., Böhm, M., Pulbrook, M., Moses, D., Shnier, R., … Stricker, P. D. (2016). Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy. BJU International , 117 (1), 48–54. https://doi.org/10.1111/bju.13090
van Leeuwen, P. J., Donswijk, M., Nandurkar, R., Stricker, P., Ho, B., Heijmink, S., … Emmett, L. (2019). Gallium-68-prostate-specific membrane antigen ((68) Ga-PSMA) positron emission  tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate c. BJU International , 124 (1), 62–68. https://doi.org/10.1111/bju.14506
van Leeuwen, P. J., Emmett, L., Ho, B., Delprado, W., Ting, F., Nguyen, Q., & Stricker, P. D. (2017). Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron  emission tomography/computed tomography for preoperative lymph node staging in prostate cancer. BJU International , 119 (2), 209–215. https://doi.org/10.1111/bju.13540
van Leeuwen, P. J., Hayen, A., Thompson, J. E., Moses, D., Shnier, R., Böhm, M., … Stricker, P. D. (2017). A multiparametric magnetic resonance imaging-based risk model to determine the risk  of significant prostate cancer prior to biopsy. BJU International , 120 (6), 774–781. https://doi.org/10.1111/bju.13814
van Leeuwen, P. J., Stricker, P., Hruby, G., Kneebone, A., Ting, F., Thompson, B., … Emmett, L. (2016). (68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the  prostatic fossa in patients being considered for salvage radiation treatment. BJU International , 117 (5), 732–739. https://doi.org/10.1111/bju.13397

Robotic Surgery

Beattie, K., Symons, J., Chopra, S., Yuen, C., Savdie, R., Thanigasalam, R., … Stricker, P. D. (2013). A novel method of bladder neck imbrication to improve early urinary continence  following robotic-assisted radical prostatectomy. Journal of Robotic Surgery , 7 (2), 193–199. https://doi.org/10.1007/s11701-012-0371-2
Cagiannos, I., Karakiewicz, P., Graefen, M., Eastham, J. A., Ohori, M., Rabbani, F., … Kattan, M. W. (2004). Is year of radical prostatectomy a predictor of outcome in prostate cancer? The Journal of Urology , 171 (2 Pt 1), 692–696. https://doi.org/10.1097/01.ju.0000107260.98031.0e
Doumerc, N., Yuen, C., Savdie, R., Rahman, M. B., Pe Benito, R., & Stricker, P. (2010). Robot-assisted laparoscopic prostatectomy: analysis of an experienced open surgeon's  learning curve after 300 procedures. Journal of Robotic Surgery , 3 (4), 229–234. https://doi.org/10.1007/s11701-010-0171-5
Doumerc, N., Yuen, C., Savdie, R., Rahman, M. B., Rasiah, K. K., Pe Benito, R., … Stricker, P. D. (2010). Should experienced open prostatic surgeons convert to robotic surgery? The real  learning curve for one surgeon over 3 years. BJU International , 106 (3), 378–384. https://doi.org/10.1111/j.1464-410X.2009.09158.x
Gondoputro, W., Scheltema, M. J., Blazevski, A., Doan, P., Thompson, J. E., Amin, A., … Stricker, P. D. (2022). Robot-assisted prostate-specific membrane antigen-radioguided surgery in primary  diagnosed prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine . https://doi.org/10.2967/jnumed.121.263743
Gondoputro, W., Thompson, J., Evans, M., Bolton, D., Frydenberg, M., Murphy, D. G., … Papa, N. (2022). How Does Age Affect Urinary Continence following Robot-Assisted Radical  Prostatectomy? A Prospective Multi-Institutional Study Using Independently Collected, Validated Questionnaires. The Journal of Urology , 101097JU0000000000002391. https://doi.org/10.1097/JU.0000000000002391
Graefen, M., Karakiewicz, P. I., Cagiannos, I., Klein, E., Kupelian, P. A., Quinn, D. I., … Kattan, M. W. (2002). Validation study of the accuracy of a postoperative nomogram for recurrence after  radical prostatectomy for localized prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical  Oncology , 20 (4), 951–956. https://doi.org/10.1200/JCO.2002.20.4.951
Graefen, M., Karakiewicz, P. I., Cagiannos, I., Quinn, D. I., Henshall, S. M., Grygiel, J. J., … Kattan, M. W. (2002). International validation of a preoperative nomogram for prostate cancer recurrence  after radical prostatectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical  Oncology , 20 (15), 3206–3212. https://doi.org/10.1200/JCO.2002.12.019
Gupta, R., O'Connell, R., Haynes, A.-M., Stricker, P. D., Barrett, W., Turner, J. J., … Kench, J. G. (2015). Extraprostatic extension (EPE) of prostatic carcinoma: is its proximity to the  surgical margin or Gleason score important? BJU International , 116 (3), 343–350. https://doi.org/10.1111/bju.12911
Karakiewicz, P. I., Eastham, J. A., Graefen, M., Cagiannos, I., Stricker, P. D., Klein, E., … Kattan, M. W. (2005). Prognostic impact of positive surgical margins in surgically treated prostate  cancer: multi-institutional assessment of 5831 patients. Urology , 66 (6), 1245–1250. https://doi.org/10.1016/j.urology.2005.06.108
Moore, B. M., Savdie, R., PeBenito, R. A., Haynes, A.-M., Matthews, J., Delprado, W., … Stricker, P. D. (2012). The impact of nerve sparing on incidence and location of positive surgical margins  in radical prostatectomy. BJU International , 109 (4), 533–538. https://doi.org/10.1111/j.1464-410X.2011.10361.x
Savdie, R., Horvath, L. G., Benito, R. P., Rasiah, K. K., Haynes, A.-M., Chatfield, M., … Kench, J. G. (2012). High Gleason grade carcinoma at a positive surgical margin predicts biochemical  failure after radical prostatectomy and may guide adjuvant radiotherapy. BJU International , 109 (12), 1794–1800. https://doi.org/10.1111/j.1464-410X.2011.10572.x
Siriwardana, A., Thompson, J., van Leeuwen, P. J., Doig, S., Kalsbeek, A., Emmett, L., … Stricker, P. (2017). Initial multicentre experience of (68) gallium-PSMA PET/CT guided robot-assisted  salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited. BJU International , 120 (5), 673–681. https://doi.org/10.1111/bju.13919
Sooriakumaran, P., Srivastava, A., Shariat, S. F., Stricker, P. D., Ahlering, T., Eden, C. G., … Tewari, A. K. (2014). A multinational, multi-institutional study comparing positive surgical margin rates  among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patients. European Urology , 66 (3), 450–456. https://doi.org/10.1016/j.eururo.2013.11.018
Thompson, J. E., Egger, S., Böhm, M., Haynes, A.-M., Matthews, J., Rasiah, K., & Stricker, P. D. (2014). Superior quality of life and improved surgical margins are achievable with robotic  radical prostatectomy after a long learning curve: a prospective single-surgeon study of 1552 consecutive cases. European Urology , 65 (3), 521–531. https://doi.org/10.1016/j.eururo.2013.10.030
Thompson, J. E., Egger, S., Böhm, M., Siriwardana, A. R., Haynes, A. M., Matthews, J., … Stricker, P. D. (2018). Superior Biochemical Recurrence and Long-term Quality-of-life Outcomes Are Achievable with Robotic Radical Prostatectomy After a Long Learning Curve—Updated Analysis of a Prospective Single-surgeon Cohort of 2206 Consecutive Cases. European Urology , 73 (5), 664–671. https://doi.org/10.1016/j.eururo.2017.11.035

Radiotherapy

Savdie, R., Symons, J., Spernat, D., Yuen, C., Pe Benito, R. A., Haynes, A.-M., … Stricker, P. D. (2012). High-dose rate brachytherapy compared with open radical prostatectomy for the  treatment of high-risk prostate cancer: 10 year biochemical freedom from relapse. BJU International , 110 Suppl , 71–76. https://doi.org/10.1111/j.1464-410X.2012.11480.x
Stevens, M. J., Stricker, P. D., Saalfeld, J., Brenner, P. C., Kooner, R., O'Neill, G. F. A., … Martland, J. (2003). Treatment of localized prostate cancer using a combination of high dose rate  Iridium-192 brachytherapy and external beam irradiation: initial Australian experience. Australasian Radiology , 47 (2), 152–160. https://doi.org/10.1046/j.0004-8461.2003.01143.x